← Back to Search

Multicomponent clinic-system strategies for Human Papillomavirus

N/A
Waitlist Available
Led By Roshan Bastani, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial will compare the effectiveness of different reminders (mailed and text) and clinic system strategies to improve HPV vaccine series completion among underserved, ethnic minority adolescents receiving care through FQHCs.

Eligible Conditions
  • Human Papillomavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HPV vaccine series completion based on electronic health record data

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Parent RemindersExperimental Treatment1 Intervention
Group II: Multicomponent clinic-system strategiesExperimental Treatment1 Intervention
Group III: Combined ConditionExperimental Treatment1 Intervention
Group IV: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,259,851 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,979,776 Total Patients Enrolled
Roshan Bastani, PhDPrincipal InvestigatorProfessor, Health Policy and Management, UCLA Fielding School of Public Health
4 Previous Clinical Trials
57,413 Total Patients Enrolled

Media Library

Multicomponent clinic-system strategies Clinical Trial Eligibility Overview. Trial Name: NCT03726151 — N/A
Human Papillomavirus Research Study Groups: Usual Care, Parent Reminders, Multicomponent clinic-system strategies, Combined Condition
Human Papillomavirus Clinical Trial 2023: Multicomponent clinic-system strategies Highlights & Side Effects. Trial Name: NCT03726151 — N/A
Multicomponent clinic-system strategies 2023 Treatment Timeline for Medical Study. Trial Name: NCT03726151 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
Roshan Bastani 2018. "Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03726151.
~2458 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top